Sunary We have examined the selective cytotoxicity of immunoliposomes containing doxorubicin (chemoimmunoliposomes, CILs) targeting the c-erbB-2 gene product (gpl85) or gpl25. Anti-gpl85 and anti-gpl25 CHLs were prepared by conjugation of doxorubicin-containing liposomes with monoclonal antibodies SER4 (IgG) and HBJ127 (IgG) respectively. Both CILs bound to human SKBr-3 breast cancer cells and MKN-7 human gastric cancer cells, which express both antigens in high density. The IC50 of anti-gpl85
We have previously examined the anti-cancer activity of doxorubicin-containing immunoliposomes (chemoimmunoliposomes, CILs) targeting a tumour-associated antigen, gp125 (Masuko et al., 1985; Suzuki et al., 1994) . In general, the anti-cancer effect of CILs would be expected to be closely related to their intracellular fate. In these previous reports, various tumour cells expressing gpl25 were analysed for endocytosis of and sensitivity to anti-gpl25 CILs. It was shown that endocytosis was not necessarily required for their cytotoxicity. However, it is unclear whether these findings were due to the specific character of gp125 as the target antigen.
c-erbB-2 is a proto-oncogene that encodes a 185 kDa cellsurface glycoprotein (Di Fiorre et al., 1987) . Amplification and overexpression of the c-erbB-2 gene has been shown in many human cancers, including 30% of lung, breast, ovary and stomach adenocarcinomas. In cases with gene amplification, there is a 50-to 100-fold increase in c-erbB-2 mRNA as compared with normal cell levels, and this overexpression has been correlated with the malignancy of cancer cells (reviewed in Di Fiorre et al., 1991) . Various antibodies directed against this antigen have been found to have significant modulatory activity (Drebin et al., 1985; Maier et al., 1991 
MAbs
Mouse MAbs HBJ127 and SER4 (both IgGl) were raised against a tumour-associated antigen, gpI25, and the c-erbB-2 product, gpI85, respectively (Masuko et al., 1985 . AL-6 (mouse IgM) was raised against immunoliposomes and recognised MBPE on liposomes (Suzuki et al., 1992) . MAbs were purified from ascites fluid of mice that had been transplanted with the corresponding hybridoma cells by 50% ammonium sulphate precipitation followed by protein G affinity chromatography for IgG or gel filtration on Sepharose CL6B for IgM.
FITC-conjugated AL-6 was prepared for determining cellsurface CILs, by coupling AL-6 with FITC at a molar ratio of 1:50. The molar ratio in the product was about 1:12. (Figure 2a, open triangles) . This among three cancer cells were almost the same ic activity was completely blocked by competition (0.45-0.62 g ml-' DOX) but slightly lower than that for :cess intact SER4 MAb (Figure 2a, closed (Figure 1 ), showed relatively low cytotoxic potential d). SER4 CILs show selective cytotoxicity also on (IC50 1.5 l1gml; Figure 2b ) compared with SER4 CILs. 7. but to a lesser degree than on SKBr-3 (IC50, Thus, cell-associated DOX at each dose in Figure 2a and b nl-' in Figure 2b ). The IC50 values of free DOX was quantified to reveal the amount of DOX required for 50% inhibition of [3H]leucine incorporation (Figure 3 ). In the case of SKBr-3 cells, it was 1 x 108 DOX molecules per cell for SER4 CILs, which was 4.5 times lower than that required for HBJ 127 CILs (Figure 3a) . Similar results were obtained for MKN-7 cells, the concentration required being 4.3 times sN-7zgrX,X,,.,,,,.,. U .............. ,.lower for SER4 CILs than for HBJ127 CILs (Figure 3b ).
We then demonstrated endocytosis of CILs by SKBr- indicating localisation on the cell surface. At 1 h it was found to be brighter and was observed in small dots beneath the cell membrane or near the nucleus, probably indicating localisation in endosomes or lysosomes. On the other hand using HBJ127 CILs after I h incubation, the fluorescence was observed both on the cell surface and as intracellular dots with a similar intensity. Under the same conditions MKN-7 showed only weak processing of SER4-CIL (Figure 5b ).
Discussio
We first examined the potential of anti-gp185 CILs (SER4 CILs) for therapeutic application. Since gpl85 is also expressed on normal cells, although at a far lower level, the magnitude of the therapeutic efficacy is based on the degree of overexpression of gp185 on the target cancer cells. As shown in Figure 1 , SER4 CILs showed higher binding to Figure 3a (Suzuki et al., 1994) . Processing of CILs might be one of the key factors for the expression of CIL cytotoxicity as it has been reported that the cytotoxicity of DOX is dependent on its reduction by cytosolic enzymes (Bartoszek and Wolf, 1992 (Drebin et al., 1985; Maier et al., 1991; our Taken together, the cytotoxic efficiency of CILs was found to be dependent not only on antigen density, but also on the cell type studied and the antigen characteristics, in particular endocytosis. These considerations are thus important in selecting useful antigens (ligand) for therapeutic application of CILs.
In conclusion, SER4 CILs showed a selective anti-cancer effect against gpl85-overexpressing SKBr-3 and MKN-7 cells, and, compared with gpl25, gpl85 was a more sensitive antigen for CIL cytotoxicity probably as a result of endocytosis activity. 
